NCT05414500 2025-08-08Mogamulizumab and Brentuximab Vedotin in CTCL and Mycosis FungoidesUniversity of Alabama at BirminghamPhase 1 Recruiting10 enrolled
NCT02616965 2025-04-04A Study to Assess the Feasibility of Romidepsin Combined With Brentuximab Vedotin in Cutaneous T-cell LymphomaFox Chase Cancer CenterPhase 1 Completed16 enrolled